Chemical and Pharmaceutical Bulletin p. 2096 - 2099 (1997)
Update date:2022-08-06
Topics:
Takeuchi, Yasuo
Kitaomo, Masayuki
Chang, Ming-Rong
Shirasaka, Shota
Shimamura, Chinami
Okuno, Yumiko
Yamato, Masatoshi
Harayama, Takashi
Indolo[3,2-b]quinoline derivatives (1b-i) with a methyl group at each possible position have been synthesized. The 1-methyl (1b) and 9-methyl (1i) derivatives were inactive, but the 3-methyl (1d), 4-methyl (1e), and 6- methyl (1f) derivatives exhibited high treatment/control (T/C) value and cure rates against leukemia P388 in mice. These results indicated that modification of indolo[3,2-b]quinoline derivatives at 3, 4, and 6 positions may be useful approach for lead optimization.
View Moreshijiazhuang alkay chemicals co..ltd(expird)
Contact:86-311-67692035
Address:2601,juntang building,qiaodong district,shijiazhuang
Wuhan Sunrise Pharmaceutical Technology Co., Ltd
Contact:+86-27-83314682
Address:Room 340, New material Industrial base No.17, Gu Tian Five Lu , Qiaokou District, Wuhan , China
Hangzhou LINGEBA Technology Co., Ltd.
Contact:+0086-571-87389059
Address:Office 1-913,NewYouth Plaza, GongShu Area, HangZhou,ZheJiang,P.R.China
website:http://www.aecochemical.com
Contact:+86-592 599 8717
Address:No 611 Sishui Road,Huli
Tianjin Pharmacn Medical Technology Co.,Ltd.
Contact:86-22-60122566ext.866(English),23359620
Address:Green Industrial Base, 6 Haitaifazhan Sixth Rd., Huayuan Industrial Area, Tianjin, 300384, China
Doi:10.1016/j.tetlet.2011.04.036
(2011)Doi:10.1016/j.crci.2010.11.001
(2011)Doi:10.1002/adsc.201000927
(2011)Doi:10.1039/c1ob05571b
(2011)Doi:10.1039/c5cc06712j
(2016)Doi:10.1016/j.bbagen.2011.03.001
(2011)
